SCHEMBL22145135

SCHEMBL22145135

COc1ccc(-n2c3ccccc3c3c4ccccc4c4c(c32)C=CC(c2ccccc2)(c2ccccc2)O4)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 1/20 0.36
MAPT P10636 5/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 4/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TP53 P04637 1/20 0.32
OXTR P30559 1/20 0.32
PPARG P37231 1/20 0.32
DRD1 P21728 1/20 0.32
DRD5 P21918 1/20 0.32
NPSR1 Q6W5P4 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32
G6PD P11413 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22145201 0.97 MAPT (0.36) EDNRAMAPTLMNAALDH1A1HPGD
SCHEMBL22145205 0.96 EDNRA (0.34) EDNRAMAPTLMNAALDH1A1HPGD
SCHEMBL22145204 0.92 L3MBTL1 (0.31) EDNRALMNAALDH1A1HPGDTP53
SCHEMBL22145250 0.91 KDM4E (0.36) EDNRAMAPTLMNAALDH1A1HPGD
SCHEMBL22145208 0.90 SMN1; SMN2 (0.35) EDNRAMAPTLMNAALDH1A1HPGD
SCHEMBL22145126 0.90 PPARG (0.38) EDNRAMAPTLMNAALDH1A1HPGD
SCHEMBL22145137 0.89 L3MBTL1 (0.37) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL22145207 0.89 KDM4E (0.33) EDNRAMAPTLMNAALDH1A1HPGD
SCHEMBL23919130 0.88 MAPT (0.36) EDNRAMAPTLMNAALDH1A1HPGD
SCHEMBL22145210 0.88 ALDH1A1 (0.31) EDNRAMAPTLMNAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3898636-B9 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-11-08 EP disclosed
EP-3898636-B1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-08-30 EP disclosed
US-20220056039-A1 Indolonaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2022-02-24 US disclosed
WO-2020126032-A1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL, LTD. (IE) 2020-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220056039-A1 Indolonaphthopyrans TPH1, TPH2, IDO1 EDNRA 204/4885MAPT 1575/4885LMNA 2683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.